{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000153,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06793-9","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:22:06Z","timestamp":1771287726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia"],"prefix":"10.1007","volume":"105","author":[{"given":"Roberta","family":"Mazzarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cicconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Domenica","family":"Divona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ceccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Nardozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Biagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Ottone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Corbingi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Panetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra Ortu","family":"La Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzurra Anna","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Pacitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Cotroneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Voso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pulsoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"6793_CR1","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/cncr.30864","volume":"123","author":"P Jain","year":"2017","unstructured":"Jain P et al (2017) Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: cohort study of 477 patients. Cancer 123:4391\u20134402","journal-title":"Cancer"},{"key":"6793_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000097920","volume":"117","author":"E Oku","year":"2007","unstructured":"Oku E et al (2007) Promyelocytic crisis of chronic myelogenous leukaemia during imatinib mesylate treatment. Acta Haematol 117:191\u2013196","journal-title":"Acta Haematol"},{"key":"6793_CR3","unstructured":"Chung HJ, Chi HS, Cho YU, Park CJ, et al (2008) Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment. Ann Clin Lab Sci 38(3):283\u20136"},{"key":"6793_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12308-012-0172-6","volume":"6","author":"D Hoehn","year":"2013","unstructured":"Hoehn D et al (2013) t(15;17)(q24.1;q21.2)\/PML-RARA in blast phase of chronic myelogenous leukemia: A rare form of clonal evolution. J Hematop 6:187\u2013193","journal-title":"J Hematop"},{"key":"6793_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3343\/alm.2021.41.3.328","volume":"41","author":"B Kim","year":"2021","unstructured":"Kim B, Chi HY, Yoon YA, Choi YJ (2021) Promyelocytic blast phase of chronic myeloid leukemia, BCR-ABL1-positive: points to be considered at diagnosis. Ann Lab Med 41:328\u2013332","journal-title":"Ann Lab Med"},{"key":"6793_CR6","first-page":"1","volume":"2020","author":"S Wolanin","year":"2020","unstructured":"Wolanin S et al (2020) PML-RARA fusion transcripts detectable 8 months prior to promyelocytic blast crisis in chronic myeloid leukemia. Case Rep Hematol 2020:1\u20138","journal-title":"Case Rep Hematol"},{"key":"6793_CR7","doi-asserted-by":"crossref","unstructured":"Parsi M, Budak-Alpdogan T (2020) Promyelocytic blast crisis of chronic myeloid leukemia in a patient undergoing therapy with a tyrosine kinase inhibitor. Cureus 12(3):e7217","DOI":"10.7759\/cureus.7217"},{"key":"6793_CR8","doi-asserted-by":"crossref","unstructured":"Abiyev A, Zengin O, Erkut Onder M, Arslan S (2017) Presentation of chronic myeloid leukemia as promyelositic blastic transformation: a case report and literature review. Clin Case Rep Rev 3(6)","DOI":"10.15761\/CCRR.1000348"},{"issue":"17","key":"6793_CR9","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1182\/blood-2010-03-276196","volume":"116","author":"F Lo-Coco","year":"2010","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Breccia M, Gallo E, Rambaldi A et al (2010) Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA group. Blood 116(17):3171\u20139","journal-title":"Blood"},{"key":"6793_CR10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","volume":"34","author":"A Hochhaus","year":"2020","unstructured":"Hochhaus A, Baccarani M, Silver RT et al (2020) European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia 34:966\u2013984","journal-title":"Leukemia"},{"key":"6793_CR11","doi-asserted-by":"publisher","unstructured":"Hughes TP, Mauro MJ, Cortes JE et al (2019) Asciminib in chronic myeloid leukemia after ABL kinase inhibitor failure. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1902328","DOI":"10.1056\/NEJMoa1902328"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06793-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06793-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06793-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:58:37Z","timestamp":1776405517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06793-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":11,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6793"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06793-9","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Informed consent was obtained from the patienta nd approval was obtained from the reference ethics committee of Santa Maria goretti Hospital (Latina). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to publish declarations"}},{"value":"Prof. Massimo Breccia, one of authors, serves as Editor-in-Chief of the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}